Historically, breast cancer has been described as immunologically cold. However, Céline Blaye, MD, University of Bordeaux, Bordeaux, France, describes findings of myeloid-derived suppressor cells within the breast cancer environment, which play a significant role in breast cancer immunosuppression. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.
